EMJ GOLD - European Medical Journal

This site is intended for healthcare professionals

Continue

EMJ GOLD

Filter Advertise With Us
Takeda logo on a large sign

Takeda R&D head Andy Plump to retire after a decade

Andy Plump, the research and development chief who overhauled Takeda’s pipeline over more than a decade, will retire in June 2027.
Lungs shape made from yellow paper on a palm old woman on a blue background

AZ's COPD drug cuts flare-ups in two phase 3 trials

AstraZeneca’s experimental COPD drug has significantly reduced flare-ups in two late-stage trials, making FDA approval in 2027 now possible.
Woman-with-headache-and-stomach-pain-lying-on-a-couch-at-home

AbbVie drug meets phase 3 goal in menstrual migraine

AbbVie’s atogepant has met the primary endpoint of its phase 3 trial, which tested the drug as a preventive treatment for menstrual migraine.
A panorama view of the Ribblehead Viaduct, Yorkshire, UK in summertime

Pharma investment on the up as UK turns corner

The UK is starting to claw back some of the pharmaceutical investment it lost in recent years, according to a new report from the ABPI.
Person performing spinal tap or lumbar puncture

New Ionis drug gets FDA greenlight for rare brain disorder

Zanvastro (zilganersen) becomes the first FDA-approved treatment for Alexander disease, a rare genetic brain disorder.
Pair of scissors cutting a piece of paper with JOBS written on it

ArsenalBio and TScan cut jobs to focus on in vivo

ArsenalBio and TScan reduce their workforces in order to focus on therapies that work by engineering patients’ cells inside the body.
Manchester skyline

MHRA launches health innovation sandbox in Manchester

Emerging healthcare technologies will be tested in real NHS settings under a new regulatory sandbox launched by the MHRA.
Novartis logo

Novartis halts eight CAR-T cell therapy trials after deaths

Novartis has halted eight rap-cell trials after three patients died following severe immune reactions.
We’ve noticed you’re accessing
from North/South America.